APPLICATION
ANDA078712
TYPE
ANDA
ORIGINAL APPROVAL
2007-12-11
LATEST ACTION
2024-09-20
ROUTE
ORAL
DOSAGE FORM
TABLET, EXTENDED RELEASE
MARKETING STATUS
Discontinued
Products
CIPROFLOXACIN EXTENDED RELEASEDiscontinued
CIPROFLOXACIN 212.6MG, CIPROFLOXACIN HYDROCHLORIDE EQ 287.5MG BASE · TABLET, EXTENDED RELEASE · ORAL
Approval history
2024-09-20Labeling · Supplement 7 · standardAP
2019-05-03Labeling · Supplement 6 · standardAP
2019-04-24Labeling · Supplement 4 · standardAP
2018-10-18Labeling · Supplement 5 · standardAP
2016-07-26Labeling · Supplement 2 · standardAP
2016-07-26Labeling · Supplement 3 · standardAP
2013-12-04Labeling · Supplement 1 · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.